Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)
NCT03240991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2018-04-17
Summary
This study aims to describe quality of life in hereditary or acquired non drug-related bradykinin-mediated angioedema patients, using validated questionnaires
Conditions
- Angioedema
Interventions
- OTHER
-
Quality of life
Dermatology Life Quality Index, Angioedema Quality of Life Questionnaire, Angioedema Activity Score
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-11
- Primary Completion
- 2016-12-01
- Completion
- 2016-12-01
Countries
- France
Study Locations
More Related Trials
-
Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
NCT00001541 ·Status: COMPLETED
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Natural History of Hypereosinophilia and Hypereosinophilic Syndromes
NCT04018118 ·Status: RECRUITING
-
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
NCT07117981 ·Status: RECRUITING
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms
NCT03688490 ·Status: COMPLETED
-
Genetic Susceptibility Factors for Candidemia.
NCT02841501 ·Status: COMPLETED
-
Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
NCT02126098 ·Status: UNKNOWN
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
NCT02474888 ·Status: TERMINATED
-
Giant Cell Arteritis - Ways to Precision Medicine
NCT07084480 ·Status: RECRUITING
-
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
NCT04664465 ·Status: RECRUITING
-
Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2
NCT03800056 ·Status: TERMINATED
-
Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)
NCT05162066 ·Status: TERMINATED ·Phase: PHASE2
-
The Natural History of Alpha-Mannosidosis
NCT00498420 ·Status: COMPLETED
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
Biomarkers in Giant Cells Arteritis
NCT02844023 ·Status: TERMINATED ·Phase: NA
-
A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen
NCT04845958 ·Status: COMPLETED
-
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
NCT06894602 ·Status: RECRUITING
-
Quality of Life in Patients With Auto-inflammatory Diseases
NCT03569644 ·Status: COMPLETED ·Phase: NA
-
Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid
NCT03622801 ·Status: COMPLETED
-
Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)
NCT05416723 ·Status: UNKNOWN
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)
NCT06636344 ·Status: RECRUITING